A Telemedicine Approach for Monitoring COPD: A Prospective Feasibility and Acceptability Cohort Study

References

• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2022 report); 2022. Available from: https://goldcopd.org/. Accessed November 4, 2022.
   Google Scholar
• Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18(1):67. doi:10.1186/s12931-017-0548-3
   PubMed Web of Science ®Google Scholar
• Anzueto A. Impact of exacerbations on COPD. Eur Respir Rev. 2010;19(116):113–118. doi:10.1183/09059180.00002610
   PubMedGoogle Scholar
• Ishii T, Nishimura M, Akimoto A, James MH, Jones P. Understanding low COPD exacerbation rates in Japan: a review and comparison with other countries. Int J Chron Obstruct Pulmon Dis. 2018;13:3459–3471. doi:10.2147/COPD.S165187
   PubMed Web of Science ®Google Scholar
• Tamaki K, Sakihara E, Miyata H, et al. Utility of Self-administered questionnaires for identifying individuals at risk of COPD in Japan: the OCEAN (Okinawa COPD casE finding AssessmeNt) study. Int J Chron Obstruct Pulmon Dis. 2021;16:1771–1782. doi:10.2147/COPD.S302259
   PubMed Web of Science ®Google Scholar
• Fukuchi Y, Fernandez L, Kuo HP, et al. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial. Respirology. 2011;16(5):825–835. doi:10.1111/j.1440-1843.2011.01982.x
   PubMed Web of Science ®Google Scholar
• Betsuyaku T, Kato M, Fujimoto K, et al. A randomized trial of symptom-based management in Japanese patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:2409–2423. doi:10.2147/COPD.S152723
   PubMed Web of Science ®Google Scholar
• Donner CF, ZuWallack R, Nici L. The role of telemedicine in extending and enhancing medical management of the patient with chronic obstructive pulmonary disease. Medicina. 2021;57(7):726. doi:10.3390/medicina57070726
   PubMed Web of Science ®Google Scholar
• McCabe C, McCann M, Brady AM. Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;5:Cd011425. doi:10.1002/14651858.CD011425.pub2
   PubMed Web of Science ®Google Scholar
• Ministry of Health LaW, Japan. Guidance for defined the procedure and requirement for telemedicine (Japanese). Available from: https://www.mhlw.go.jp/file/05-Shingikai-10801000-Iseikyoku-Soumuka/0000201789.pdf2018. Accessed November 4, 2022.
   Google Scholar
• Miyawaki A, Tabuchi T, Ong MK, Tsugawa Y. Age and social disparities in the use of telemedicine during the COVID-19 pandemic in Japan: cross-sectional study. J Med Internet Res. 2021;23(7):e27982. doi:10.2196/27982
   PubMed Web of Science ®Google Scholar
• Kato M, Tomii K, Hashimoto K, et al. The IMPACT study - single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: efficacy and safety in a Japanese population. Int J Chron Obstruct Pulmon Dis. 2019;14:2849–2861. doi:10.2147/COPD.S226601
   PubMed Web of Science ®Google Scholar
• Integrity Healthcare Co. Ltd. The YaDoc telemonitoring platform (Japanese); 2022. Available from: https://www.yadoc.jp/about/feature. Accessed May 16, 2019.
   Google Scholar
• Personal Information Protection Commission Japan. Amended act of the protection of personal information; 2016.
   Google Scholar
• Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–946. doi:10.1183/09031936.04.00014304
   PubMed Web of Science ®Google Scholar
• Tamaoki A. Diagnosis and Treatment for ACO. Intern Med. 2018;107(9):1852–1857.
   Google Scholar
• Yamamura K, Hara J, Kobayashi T, et al. The prevalence and clinical features of asthma-COPD overlap (ACO) definitively diagnosed according to the Japanese Respiratory Society Guidelines for the Management of ACO. J Medical Invest. 2019;66(1.2):157–164. doi:10.2152/jmi.66.157
   PubMed Web of Science ®Google Scholar
• Government of Japan. [COVID-19] the declaration of the lifting of the state of emergency in response to the novel coronavirus disease; 2020. Available from: https://japan.kantei.go.jp/ongoingtopics/_00027.html. Accessed November 4, 2022.
   Google Scholar
• North M, Bourne S, Green B, et al. A randomised controlled feasibility trial of E-health application supported care vs usual care after exacerbation of COPD: the RESCUE trial. Npj Digital Med. 2020;3(1):145. doi:10.1038/s41746-020-00347-7
   PubMed Web of Science ®Google Scholar
• Cordova FC, Ciccolella D, Grabianowski C, et al. A telemedicine-based intervention reduces the frequency and severity of COPD exacerbation symptoms: a randomized, controlled trial. Telemed J E Health. 2016;22(2):114–122. doi:10.1089/tmj.2015.0035
   PubMed Web of Science ®Google Scholar
• Smith HS, Criner AJ, Fehrle D, Grabianowski CL, Jacobs MR, Criner GJ. Use of a smartphone/tablet-based bidirectional telemedicine disease management program facilitates early detection and treatment of COPD exacerbation symptoms. Telemed J E Health. 2016;22(5):395–399. doi:10.1089/tmj.2015.0135
   PubMed Web of Science ®Google Scholar
• Rassouli F, Baty F, Stolz D, et al. Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk. Int J Chron Obstruct Pulmon Dis. 2017;12:3103–3109. doi:10.2147/copd.s141646
   PubMed Web of Science ®Google Scholar
• Willard-Grace R, Chirinos C, Wolf J, et al. Lay health coaching to increase appropriate inhaler use in COPD: a randomized controlled trial. Ann Fam Med. 2020;18(1):5–14. doi:10.1370/afm.2461
   PubMed Web of Science ®Google Scholar
• Almathami HKY, Win KT, Vlahu-Gjorgievska E. Barriers and facilitators that influence telemedicine-based, real-time, online consultation at patients’ homes: systematic literature review. J Med Internet Res. 2020;22(2):e16407. doi:10.2196/16407
   PubMed Web of Science ®Google Scholar
• Shahrabani S, Mizrachi Y. Factors affecting compliance with use of online healthcare services among adults in Israel. Isr J Health Policy Res. 2016;5:15. doi:10.1186/s13584-016-0073-8
   PubMed Web of Science ®Google Scholar
• Cook EJ, Randhawa G, Sharp C, et al. Exploring the factors that influence the decision to adopt and engage with an integrated assistive telehealth and telecare service in Cambridgeshire, UK: a nested qualitative study of patient ‘u/sers’ and ‘non-users’. BMC Health Serv Res. 2016;16:137. doi:10.1186/s12913-016-1379-5
   PubMed Web of Science ®Google Scholar
• Rho MJ, Choi IY, Lee J. Predictive factors of telemedicine service acceptance and behavioral intention of physicians. Int J Med Inform. 2014;83(8):559–571. doi:10.1016/j.ijmedinf.2014.05.005
   PubMed Web of Science ®Google Scholar
• Soriano JB, García-Río F, Vázquez-Espinosa E, et al. A multicentre, randomized controlled trial of telehealth for the management of COPD. Respir Med. 2018;144:74–81. doi:10.1016/j.rmed.2018.10.008
   PubMed Web of Science ®Google Scholar
• Mínguez Clemente P, Pascual-Carrasco M, Mata Hernández C, et al. Follow-up with telemedicine in early discharge for COPD exacerbations: randomized clinical trial (TELEMEDCOPD-trial). COPD. 2021;18(1):62–69. doi:10.1080/15412555.2020.1857717
   PubMedGoogle Scholar
• Coleman C. Health literacy and clear communication best practices for telemedicine. Health Lit Res Pract. 2020;4(4):e224–e229. doi:10.3928/24748307-20200924-01
   PubMedGoogle Scholar
• Tabak M, Brusse-Keizer M, van der Valk P, Hermens H, Vollenbroek-Hutten M. A telehealth program for self-management of COPD exacerbations and promotion of an active lifestyle: a pilot randomized controlled trial. Int J Chron Obstruct Pulmon Dis. 2014;9:935. doi:10.2147/COPD.S60179
   PubMed Web of Science ®Google Scholar
• Calvo GS, Gómez-Suárez C, Soriano J, et al. A home telehealth program for patients with severe COPD: the PROMETE study. Respir Med. 2014;108(3):453–462. doi:10.1016/j.rmed.2013.12.003
   PubMed Web of Science ®Google Scholar